← The Lantern · New Carlisle
health · class ii

Bridge to Life Ltd recalls Bridge to Life EasiSlush, (Sodium Chloride Solution for Sterile Slush…

The stated reason: The firm issued a field safety notice after becoming aware of three lots of products not having quarterly dose audits being completed on time in the first quarter of 2024.

Illustration: a small clinic exam room with an exam table, a stethoscope and a clipboard
Illustration · The Lantern

Bridge to Life Ltd began a medical device recall on June 12, 2025 whose reported distribution included Ohio. FDA

What the record shows

Routine lot by lot testing was completed properly however the quarterly dose audit (sampling/testing to monitor the gamma steri… FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 4528 units. The recall is listed as ongoing. FDA

1 source

Context

This is one of 10 records of this type (Class Ii) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2880 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: June 12, 2025 FDA
  • Recall number: Z-2157-2025 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: Bridge to Life Ltd FDA
  • Product: Bridge to Life EasiSlush, (Sodium Chloride Solution for Sterile Slush Preparation) (0.9% Sodium Chloride Irrigation… FDA
  • Reason for recall: The firm issued a field safety notice after becoming aware of three lots of products not having quarterly dose audits… FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

The source filing

Recall numberZ-2157-2025
Recalls in this action1
Recalling firmBridge to Life Ltd
ProductBridge to Life EasiSlush, (Sodium Chloride Solution for Sterile Slush Preparation) (0.9% Sodium Chloride Irrigation, USP), Part Number REF BTLE-1250
Reason for recallThe firm issued a field safety notice after becoming aware of three lots of products not having quarterly dose audits being completed on time in the first quarter of 2024. Routine lot by lot testing was completed properly however the quarterly dose audit (sampling/testing to monitor the gamma sterilization process and confirm the validated parameters remain effective to assure sterility and bioburden reduction per requirements) was not completed on time.
ClassificationClass II — use may cause temporary or medically reversible health consequences
Recall typemedical device
Quantity4528 units
StatusOngoing
Voluntary or mandatedVoluntary: Firm initiated
Initiated20250612
Reported20250730
DistributionUnited States - New York, Maryland, Alabama, North Carolina, South Carolina, Ohio, Florida, Wisconsin, Utah, Tennessee, New Jersey, Georgia, Nebraska, Arizona, Minnesota, California, and Canada
Firm locationNorthbrook, IL, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.